Predicting Heart Failure Decompensation Before It Happens
CardiaMetrics combines low-invasive implant biomarkers and AI to enable early detection, reduce hospitalizations, and transform chronic cardiac care.
Trusted By
The Urgent Need for Innovation
Heart failure is one of the most expensive and deadly chronic conditions worldwide.
Millions of patients suffer from recurring decompensation episodes, leading to frequent hospital readmissions that drive massive healthcare costs.
Clinicians often detect decompensation too late, emphasizing the urgent need for a reliable way to predict deterioration early, before symptoms appear.
A Revolutionary Approach to Cardiac Monitoring
A New Standard for Heart Failure Monitoring
Early intervention before emergency hospitalization
Improved patient outcomes
Reduced burden on healthcare systems
Understanding Our Solution
Step 1
Data Collection
Our low-invasive sensors continuously monitor vital cardiac biomarkers, ensuring a comprehensive overview of the patient’s heart health.
Step 2
AI Analysis
Advanced AI algorithms analyze the collected data to identify patterns that predict potential heart failure decompensation.
Step 3
Clinical Alerts
Clinicians receive timely alerts, enabling proactive medication adaptations and reducing the risk of emergency hospitalizations.
Clinical Achievements
Momentum and Validation
Partnerships with leading hospital centers
Ongoing clinical evaluation and validation
Patients
Seed funding already secured
Market Potential
The digital cardiology market is rapidly expanding, driven by the demand for innovative solutions in remote monitoring and predictive care.
CardiaMetrics is strategically positioned to capture a significant share of this market, offering AI-enabled tools that meet the needs of hospitals and healthcare providers.
With an aging population and increasing prevalence of chronic heart conditions, the need for effective cardiac care solutions is more urgent than ever.
CardiaMetrics is targeting a multi-million-euro opportunity, aiming to revolutionize cardiac remote care with cutting-edge technology.
People globaly
%
People after 70 years-old
%
Patients / yr
Direct cost / yr
Hospitalizations / yr
Meet Our Experts
Our Leadership Team
Thibault Parmentier
CEO & co-founder
Rowing brought me to Grenoble, where I completed my studies with a PhD in Artificial Intelligence, focusing on knowledge representation. Like a true Grenoblois, R&D and IT were my main fields of interest for 15 years before embracing health through prevention with EIT Health.
I met Mathieu while managing the Grenoble branch of the service company Viseo, and later I discovered Cindy and the Medtech startup world as CTO & COO at SentinHealth. All together, with Rémi, we decided to found CardiaMetrics, each of us contributing our perspective to help address the challenges of aging and dependency.
Cindy Michel
CSO & co-founder
Passionate about physiology, I first studied biology before specializing in medical device engineering. My growing interest in cardiology led me to Brisbane, where I became aware of the magnitude of the challenges related to heart failure.
After my studies, I had the opportunity to join a start-up in its early stages, where I conducted a thesis on an innovative implantable medical device. I not only contributed to research but also to product development and team management, thus blending science and entrepreneurship.
Committed to providing patients and healthcare systems with innovative solutions for aging well at home and easing the mental burden of managing chronic conditions, I co-founded CardiaMetrics.
Today, as the scientific director, I passionately continue the mission of transforming heart failure management by offering technological alternatives to as many people as possible.
Rémi Sabatier
CMO & co-founder
Interventional cardiologist at CHU de Caen Normandie, specialized since 2005 in medical telemonitoring and an active contributor to its integration into mainstream healthcare in France. I am, in search of solutions providing reliable data to remotely manage my patients.
I saw in CardiaMetrics a great opportunity to bring my expertise and network to an exciting project and to directly contribute to the emergence of a relevant and effective solution.
Aurélien Bouvier
CTO & former Google Health
I am a technology executive specializing in the development of innovative medical devices and digital health solutions, with previous experience at Verily / Google Health.
Throughout my career, I have led multidisciplinary engineering teams across wearable technologies, neurotechnology, connected medical devices, and artificial intelligence-driven healthcare solutions. Before joining CardiaMetrics, I held leadership positions within internationally recognized healthcare technology organizations, including Verily, where I contributed to the development of advanced medical devices integrating physiological monitoring, neurostimulation, and surgical visualization technologies.
As Chief Technology Officer at CardiaMetrics, I lead the development of our technology platform, integrating implantable sensing technologies, artificial intelligence, cloud infrastructure, and clinical decision-support tools. My role is to help transform scientific innovation into robust, secure, and scalable solutions designed to support the early detection and prevention of heart failure decompensation.
Lamia Stephan
Chief QARA Officer
I am a biomedical engineer specializing in Quality Assurance, Regulatory Affairs and Clinical Strategy for innovative medical devices.
Throughout my career, I have supported medical technologies from development through clinical validation and market access. Prior to joining CardiaMetrics, I spent nearly six years at Nurea, where I led Quality and Regulatory Affairs, implemented an ISO 13485-certified Quality Management System, supported the market introduction of several medical software solutions, including a Class IIb device under the European MDR, and managed multiple clinical studies.
As Chief QARA Officer at CardiaMetrics, I lead our quality, regulatory and clinical strategy, ensuring that the development of our technology meets the highest standards of safety, performance and regulatory compliance. My role is to build a robust pathway from innovation to clinical validation and ultimately market access, supporting CardiaMetrics’ ambition to bring a new generation of cardiac monitoring solutions to patients.
Mathieu Ruhlmann
Head of Software & co-founder
With 20 years of experience in software development, where I had the opportunity to work on a wide variety of projects and scopes, tackle complex data management issues, and closely follow major technological advances such as artificial intelligence, I was eager to join the founding team of CardiaMetrics to take on a new challenge that is not only technological and human, but also meaningful for our society.
The proximity of my family environment to the health field made me aware of the many challenges our healthcare system faces today. I am convinced that the project we are pursuing will be beneficial for patients while easing the pressure on the healthcare system, which is why I will put all my energy into developing our product so that it can reach the market.
Partner with Us in Revolutionizing Cardiac Care
CardiaMetrics invites you to join us in our mission to transform heart failure care through innovative technology and predictive analytics. As we open our next investment round, we offer you the opportunity to be part of a groundbreaking journey that promises to redefine cardiac health management. Take the next step with us and be at the forefront of medical innovation.
